Cargando…
Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?
BACKGROUND: Renal fibrosis is the result of the interaction of cellular and molecular pathways, which is induced by sustained glomerular injury and involves the podocytes and multiple profibrotic factors. In this study, we investigated the correlation of the mRNA expression of podocyte proteins and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586273/ https://www.ncbi.nlm.nih.gov/pubmed/31220088 http://dx.doi.org/10.1371/journal.pone.0217585 |
_version_ | 1783428864164233216 |
---|---|
author | Lopes, Tiago Giulianni de Souza, Maysa Lucena da Silva, Vinicius Duval dos Santos, Mariane da Silva, William Israel Cardoso Itaquy, Thiago Pereira Garbin, Henrique Iahnke Veronese, Francisco Veríssimo |
author_facet | Lopes, Tiago Giulianni de Souza, Maysa Lucena da Silva, Vinicius Duval dos Santos, Mariane da Silva, William Israel Cardoso Itaquy, Thiago Pereira Garbin, Henrique Iahnke Veronese, Francisco Veríssimo |
author_sort | Lopes, Tiago Giulianni |
collection | PubMed |
description | BACKGROUND: Renal fibrosis is the result of the interaction of cellular and molecular pathways, which is induced by sustained glomerular injury and involves the podocytes and multiple profibrotic factors. In this study, we investigated the correlation of the mRNA expression of podocyte proteins and profibrotic factors with renal fibrosis measured in renal biopsies of patients with primary and secondary glomerulopathies. METHODS: Eighty-four adult patients with primary or secondary glomerular diseases and 12 controls were included. Demographic and clinical data were collected. Seventy-two percent of the renal biopsies were done less than one year from clinical disease manifestation. The quantification of the podocyte-associated mRNAs of alpha-actinin-4, podocin, and podocalyxin, as well as of the profibrotic factors TGF-β1, CTGF, and VEGF-A were quantified by real-time polymerase chain reaction. The percent positive area of renal fibrosis was measured by immunohistochemistry staining, using anti-CTGF and anti-HHF35 antibodies and unpolarized Sirius Red. Correlations between the expression of tissue mRNAs and the positive area of fibrosis for the measured markers were made by Spearman’s rank correlation coefficient. RESULTS: In relation to control biopsies, podocyte-specific proteins were downregulated in podocytopathies, in proliferative nephritis, in diabetic kidney disease (DRD), and in IgA nephropathy (IgAN). Messenger RNA of TGF-β1, CTGF, and VEGF-A was upregulated in patients with podocytopathies and in DRD but not in proliferative nephritis and IgAN. Tissue mRNA expression of TGF-β1, CTGF, and VEGF-A were strongly correlated with renal fibrosis, as measured by HHF35; however, the correlation, albeit significant, was moderate for Sirius Red and weak for CTGF. The percent positive area of renal fibrosis measured by Sirius Red was similar between podocytopathies and DRD and significantly higher in podocytopathies compared to IgAN or proliferative nephritis. CONCLUSIONS: In patients with glomerular diseases, the mRNA of TGF-β1, CTGF, and VEGF-A correlated positively with the extent of renal fibrosis, and the positive area of fibrosis was larger in the podocytopathies and in DRD as measured by Sirius Red. The pathways connecting podocyte damage and activation of profibrotic factors to kidney tissue fibrosis need to be better investigated. |
format | Online Article Text |
id | pubmed-6586273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-65862732019-06-28 Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases? Lopes, Tiago Giulianni de Souza, Maysa Lucena da Silva, Vinicius Duval dos Santos, Mariane da Silva, William Israel Cardoso Itaquy, Thiago Pereira Garbin, Henrique Iahnke Veronese, Francisco Veríssimo PLoS One Research Article BACKGROUND: Renal fibrosis is the result of the interaction of cellular and molecular pathways, which is induced by sustained glomerular injury and involves the podocytes and multiple profibrotic factors. In this study, we investigated the correlation of the mRNA expression of podocyte proteins and profibrotic factors with renal fibrosis measured in renal biopsies of patients with primary and secondary glomerulopathies. METHODS: Eighty-four adult patients with primary or secondary glomerular diseases and 12 controls were included. Demographic and clinical data were collected. Seventy-two percent of the renal biopsies were done less than one year from clinical disease manifestation. The quantification of the podocyte-associated mRNAs of alpha-actinin-4, podocin, and podocalyxin, as well as of the profibrotic factors TGF-β1, CTGF, and VEGF-A were quantified by real-time polymerase chain reaction. The percent positive area of renal fibrosis was measured by immunohistochemistry staining, using anti-CTGF and anti-HHF35 antibodies and unpolarized Sirius Red. Correlations between the expression of tissue mRNAs and the positive area of fibrosis for the measured markers were made by Spearman’s rank correlation coefficient. RESULTS: In relation to control biopsies, podocyte-specific proteins were downregulated in podocytopathies, in proliferative nephritis, in diabetic kidney disease (DRD), and in IgA nephropathy (IgAN). Messenger RNA of TGF-β1, CTGF, and VEGF-A was upregulated in patients with podocytopathies and in DRD but not in proliferative nephritis and IgAN. Tissue mRNA expression of TGF-β1, CTGF, and VEGF-A were strongly correlated with renal fibrosis, as measured by HHF35; however, the correlation, albeit significant, was moderate for Sirius Red and weak for CTGF. The percent positive area of renal fibrosis measured by Sirius Red was similar between podocytopathies and DRD and significantly higher in podocytopathies compared to IgAN or proliferative nephritis. CONCLUSIONS: In patients with glomerular diseases, the mRNA of TGF-β1, CTGF, and VEGF-A correlated positively with the extent of renal fibrosis, and the positive area of fibrosis was larger in the podocytopathies and in DRD as measured by Sirius Red. The pathways connecting podocyte damage and activation of profibrotic factors to kidney tissue fibrosis need to be better investigated. Public Library of Science 2019-06-20 /pmc/articles/PMC6586273/ /pubmed/31220088 http://dx.doi.org/10.1371/journal.pone.0217585 Text en © 2019 Lopes et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Lopes, Tiago Giulianni de Souza, Maysa Lucena da Silva, Vinicius Duval dos Santos, Mariane da Silva, William Israel Cardoso Itaquy, Thiago Pereira Garbin, Henrique Iahnke Veronese, Francisco Veríssimo Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases? |
title | Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases? |
title_full | Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases? |
title_fullStr | Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases? |
title_full_unstemmed | Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases? |
title_short | Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases? |
title_sort | markers of renal fibrosis: how do they correlate with podocyte damage in glomerular diseases? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586273/ https://www.ncbi.nlm.nih.gov/pubmed/31220088 http://dx.doi.org/10.1371/journal.pone.0217585 |
work_keys_str_mv | AT lopestiagogiulianni markersofrenalfibrosishowdotheycorrelatewithpodocytedamageinglomerulardiseases AT desouzamaysalucena markersofrenalfibrosishowdotheycorrelatewithpodocytedamageinglomerulardiseases AT dasilvaviniciusduval markersofrenalfibrosishowdotheycorrelatewithpodocytedamageinglomerulardiseases AT dossantosmariane markersofrenalfibrosishowdotheycorrelatewithpodocytedamageinglomerulardiseases AT dasilvawilliamisraelcardoso markersofrenalfibrosishowdotheycorrelatewithpodocytedamageinglomerulardiseases AT itaquythiagopereira markersofrenalfibrosishowdotheycorrelatewithpodocytedamageinglomerulardiseases AT garbinhenriqueiahnke markersofrenalfibrosishowdotheycorrelatewithpodocytedamageinglomerulardiseases AT veronesefranciscoverissimo markersofrenalfibrosishowdotheycorrelatewithpodocytedamageinglomerulardiseases |